文献速递甲状腺疾病

乙醇消融治疗甲状腺乳头状癌转移性淋巴结的长期疗效

Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究对2011年研究中接受乙醇消融(EA)治疗甲状腺乳头状癌(PTC)转移性淋巴结的成人患者进行长期随访,51例中44例复查、7例死亡,中位随访自初次手术14.5年、自末次EA 11.3年。多数患者(80%)获得永久局部控制,10例患者13个转移灶出现消融淋巴结内复发,无严重副作用。结论提示EA微创、并发症风险低,数据提示其安全有效,长期为大部分患者提供良好结果。

要点

  • 中位随访自初次手术14.5年,自2011年研究中末次EA 11.3年。
  • 80%患者获得永久局部控制,10例患者13个转移灶出现消融淋巴结内复发。
  • 无严重副作用报告,EA为微创且并发症风险低的治疗。

核心结论

  • EA是一种微创操作,并发症风险低;我们的数据提示EA是安全有效的治疗,长期为大部分患者提供良好结果。

研究设计与样本

  • 对2011年已发表研究中在三级转诊中心接受淋巴结转移EA治疗的成人PTC患者进行随访研究,51/63例纳入,44例复查(67/109个病灶),7例死亡。

主要发现

  • 自初次手术中位随访14.5年,自2011年研究中末次EA中位随访11.3年。
  • 大多数患者(80%)永久获得局部控制。
  • 10例患者中13个转移灶登记为消融淋巴结内复发,其中7例患者颈部其他部位也有复发。
  • 未报告严重副作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Ethanol ablation (EA) is considered an alternative to surgery for metastatic lymph nodes from papillary thyroid carcinoma (PTC) in selected patients. OBJECTIVE: The aim of this study was to evaluate the long-term efficacy and safety of this treatment. DESIGN AND SETTING: Adult patients with PTC who had received EA in lymph node metastasis at a tertiary referral center, and were included in a published study from 2011, were invited to participate in this follow-up study. METHODS: Radiologic and medical history were reviewed. Ultrasound examination of the neck was performed by radiologists, and clinical examination was performed by an endocrine surgeon. Response was reported according to predefined criteria for satisfactory EA treatment. Adverse events associated with EA were evaluated. Cause of death was reported for deceased patients. RESULTS: From the 2011 study, 51 of 63 patients were included. Forty-four patients were reexamined (67/109 lesions) and 7 patients were deceased. Median follow-up time from primary surgery was 14.5 years. Median follow-up from the latest performed EA in the 2011 study was 11.3 years. Local control was permanently achieved in most patients (80%). Recurrence within an ablated node was registered in 13 metastases in 10 patients. Seven of these patients also had recurrent disease elsewhere in the neck. No major side effects were reported. CONCLUSION: EA is a minimally invasive procedure with a low risk of complications. Our data suggest that EA is a safe and efficient treatment, providing excellent results for a large group of patients in the long term.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Frich PS, Sigstad E, Berstad AE, et al. Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2022. PMID: 34922379. doi:10.1210/clinem/dgab907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。